GO:0010890 positive regulation of triglyceride storage: Lipid Droplet Biology, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010890 describes any process that increases the rate, frequency or extent of sequestering triglyceride, the storage form of metabolic energy in lipid droplets.
• Triglyceride storage is dynamically balanced with lipolysis; excessive storage without matching oxidation contributes to lipotoxicity in obesity and metabolic disease.
• Key regulators include lipid droplet proteins (PLIN family), triglyceride synthesis enzymes (DGAT1/2), and transcription factors such as PPAR gamma and SREBP1c [1,4].
• Somatic mutations in metabolism genes, including those controlling lipid handling, are enriched in chronic liver disease and may alter triglyceride storage capacity.
• In cancer, lipid metabolic reprogramming drives triglyceride storage and influences sensitivity to FASN inhibition, linking GO:0010890 to therapy response.
• MicroRNAs such as miR-192* and mitophagy regulators such as PINK1 can impair or remodel adipocyte triglyceride storage, providing tractable experimental entry points [3,5].
Description
Triglycerides are the principal form of stored metabolic energy in eukaryotic cells, and their regulated sequestration into lipid droplets is essential for energy homeostasis. The Gene Ontology term GO:0010890, positive regulation of triglyceride storage, captures any process that increases the rate, frequency or extent of sequestering triglyceride, where sequestration means binding or confining the triester of glycerol away from other cellular components. This term sits at the intersection of lipid synthesis, lipid droplet biology, and endocrine control of energy balance, and it is increasingly recognized as a determinant of metabolic disease, liver pathology, and cancer cell survival [1,2,6]. For researchers, GO:0010890 is not a single pathway but an integrative annotation that can be satisfied by diverse molecular events: increased diacylglycerol acyltransferase activity, stabilization of lipid droplet coat proteins, enhanced fatty acid uptake and re-esterification, or suppression of lipolysis [1,4,5]. Because triglyceride storage is a quantitative trait, its positive regulation is often studied through gain-of-function and loss-of-function perturbations in adipocytes, hepatocytes, and cancer cell lines [5,6]. Understanding which genes causally increase triglyceride sequestration, and under what metabolic context, is central to dissecting obesity, steatotic liver disease, and endocrine-resistant cancers [1,2,6]. This article synthesizes the QuickGO definition of GO:0010890 with verified PubMed literature to outline the biological process, the key genes and proteins involved, disease connections, and the CRISPR-based and multi-omics methods used to study positive regulation of triglyceride storage [1,2,3,4,5,6,7,8].
positive regulation of triglyceride storage At A Glance
| GO ID | GO:0010890 |
|---|---|
| GO term | positive regulation of triglyceride storage |
| Ontology | biological_process |
| Synonym | positive regulation of sequestering of triacylglycerol; positive regulation of sequestering of triglyceride; positive regulation of triglyceride sequestration |
| Major function | Increases the rate, frequency or extent of triglyceride sequestration into storage compartments such as lipid droplets |
| Definition source concept | Any process that increases the rate, frequency or extent of sequestering of triglyceride |
| Biological context | Adipocyte lipid storage, hepatic steatosis, cancer lipid reprogramming, endocrine and inflammatory energy regulation |
| Representative regulators | DGAT1, DGAT2, PLIN1, PLIN2, PPARG, SREBF1, miR-192*, PINK1 |
| Related process | Lipid storage, lipolysis, and lipotoxicity in obesity |
What Is GO:0010890?
GO:0010890 (positive regulation of triglyceride storage) is a biological process term defined as any process that increases the rate, frequency or extent of sequestering of triglyceride. Triglyceride sequestration is the process of binding or confining any triester of glycerol such that it is separated from other components of a biological system. In practice, this means gene products and pathways that promote the accumulation of triglyceride within dedicated storage compartments, typically cytosolic lipid droplets, rather than leaving it as free lipid or directing it to oxidation.
Why Is positive regulation of triglyceride storage Important in Cell Biology?
Positive regulation of triglyceride storage is important because the capacity to safely sequester triglyceride determines whether excess fatty acids are buffered in inert lipid droplets or spill over into toxic lipid species that impair cellular function. This balance is central to obesity, insulin resistance, and fatty liver disease, where excessive triglyceride storage in adipose and non-adipose tissues is a hallmark [1,2]. At the same time, the same process can be co-opted by cancer cells to support membrane synthesis, energy supply, and survival under stress, influencing sensitivity to metabolic inhibitors such as FASN inhibitors. Understanding GO:0010890 therefore has direct implications for metabolic disease, oncology, and endocrine-inflammatory crosstalk [1,6,7].
• Buffers excess fatty acids into inert triglyceride stores, limiting lipotoxic damage to cells.
• Determines adipose tissue expandability and systemic energy balance in obesity.
• Contributes to hepatic steatosis and chronic liver disease progression when dysregulated.
• Supports cancer cell lipid metabolic reprogramming and therapy resistance.
• Is modulated by endocrine and inflammatory signals that coordinate energy and volume regulation.
• Is influenced by neuroendocrine factors such as FGF21 that alter lipid handling.
• Can be impaired by microRNAs such as miR-192*, reducing adipocyte triglyceride storage.
• Is linked to mitophagy and mitochondrial quality control through PINK1-dependent remodeling.
• Provides a quantitative phenotype for CRISPR screens and lipid droplet imaging [5,6].
• Serves as a mechanistic node connecting cholesterol and triglyceride storage regulation in fat cells.
What Happens During positive regulation of triglyceride storage?
Fatty acid uptake and activation
In simple terms: Cells first bring fatty acids in and switch them on so they can be assembled into storage fat.
Positive regulation of triglyceride storage begins with increased availability of fatty acids, either from circulating lipids or from de novo synthesis, and their activation to acyl-CoA derivatives. In adipocytes and hepatocytes, enhanced fatty acid uptake and activation shifts the balance toward esterification rather than oxidation, providing substrate for triglyceride assembly. This step is a prerequisite for net triglyceride accumulation and is often upregulated in obesity and steatotic liver disease [1,2].
Glycerol backbone supply and esterification
In simple terms: The cell builds a glycerol backbone and attaches fatty acids to it step by step to make triglyceride.
Triglyceride synthesis requires a glycerol-3-phosphate backbone and sequential acylation reactions. Positive regulation of triglyceride storage can be achieved by increasing the activity or expression of enzymes that catalyze these esterification steps, including the final committed step mediated by diacylglycerol acyltransferases. In fat cells, regulation of lipid synthesis and storage is coordinated with cholesterol metabolism, reflecting shared precursor and regulatory logic.
Lipid droplet formation and growth
In simple terms: Newly made fat is packaged into oil-like droplets that grow and are coated by protective proteins.
Once synthesized, triglyceride is sequestered into lipid droplets, which are coated by perilipin family proteins and other factors that stabilize the droplet and regulate access by lipases. Positive regulation of triglyceride storage involves both the initial nucleation of lipid droplets and their subsequent growth, processes that are sensitive to the abundance of coat proteins and to the local lipid environment [1,5]. MicroRNA-192* has been shown to impair adipocyte triglyceride storage, indicating that droplet growth and maintenance are actively regulated.
Suppression of lipolysis
In simple terms: To keep fat stored, the cell must also slow down the enzymes that would break the droplets apart.
Net triglyceride storage is the balance between synthesis and lipolysis. Positive regulation of triglyceride storage can therefore be achieved by reducing the rate of lipolytic breakdown, for example through changes in perilipin phosphorylation, lipase recruitment, or signaling downstream of endocrine cues [1,7]. Endocrine and inflammatory signals interact to modulate energy and volume regulation, indirectly influencing whether triglyceride is retained or mobilized.
Mitochondrial and mitophagy remodeling
In simple terms: The cell adjusts its power plants, which changes how much fat it burns versus stores.
Mitochondrial function and mitophagy influence the fate of fatty acids, and remodeling of lipid metabolism through the STAT2/SLC27A3/PINK1 axis has been linked to altered triglyceride handling in clear cell renal cell carcinoma. When mitochondrial fatty acid oxidation is reduced or redirected, more substrate is available for sequestration into triglyceride stores, effectively contributing to positive regulation of triglyceride storage.
Key Genes Involved in GO:0010890 positive regulation of triglyceride storage
The following genes and proteins represent well-documented contributors to positive regulation of triglyceride storage across adipocyte, hepatic, and cancer cell contexts.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DGAT1 | Catalyzes the final step of triglyceride synthesis | Target for modulating triglyceride storage capacity in adipocytes and hepatocytes |
| DGAT2 | Catalyzes diacylglycerol acylation in triglyceride synthesis | Isoform-specific regulation of lipid droplet formation |
| PLIN1 | Lipid droplet coat protein that restricts lipolysis | Key determinant of adipocyte triglyceride retention |
| PLIN2 | Lipid droplet coat protein stabilizing stored lipid | Marker and regulator of lipid droplet accumulation |
| PPARG | Master transcription factor of adipocyte lipid storage | Controls expression of triglyceride storage genes |
| SREBF1 | Transcription factor promoting lipogenic gene expression | Upstream regulator of triglyceride synthesis programs |
| FASN | Fatty acid synthase providing substrate for storage | Linked to triglyceride storage and inhibitor sensitivity in cancer |
| SCD | Desaturase modifying fatty acids for storage | Modulates triglyceride composition and droplet dynamics |
| SLC27A3 | Fatty acid transport protein family member | Implicated in mitophagy-linked lipid remodeling |
| PINK1 | Mitophagy regulator influencing lipid metabolism | Connects mitochondrial quality control to triglyceride handling |
| STAT2 | Transcription factor in interferon and metabolic signaling | Part of the STAT2/SLC27A3/PINK1 lipid remodeling axis |
| miR-192* | MicroRNA that impairs adipocyte triglyceride storage | Negative regulator useful for gain-of-storage studies |
| FGF21 | Neuroendocrine metabolic regulator | Modulates lipid handling and energy balance |
| NR1H3 (LXR alpha) | Nuclear receptor linked to lipid synthesis and storage | Regulates cholesterol and triglyceride storage programs |
| CEBPA | Adipogenic transcription factor | Supports expression of lipid storage machinery |
| CIDEC | Lipid droplet protein promoting unilocular droplet formation | Enhances triglyceride storage capacity |
| G0S2 | Inhibitor of adipose triglyceride lipase | Suppresses lipolysis to favor storage |
How Is positive regulation of triglyceride storage Regulated?
Positive regulation of triglyceride storage is controlled by a layered network of transcriptional, post-transcriptional, and endocrine inputs. Transcription factors such as PPARG and SREBF1 promote expression of lipogenic and lipid droplet genes, while microRNAs such as miR-192* can suppress storage capacity [1,5]. Endocrine and inflammatory signals interact to coordinate energy and volume regulation, influencing whether triglyceride is retained or mobilized. Neuroendocrine factors such as FGF21 can modulate lipid handling and energy balance, providing systemic control over storage. At the organelle level, mitophagy and mitochondrial remodeling through the STAT2/SLC27A3/PINK1 axis can redirect fatty acids toward storage. Together, these layers ensure that triglyceride sequestration is matched to nutrient availability and whole-body energy demand [1,7,8].
positive regulation of triglyceride storage and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DGAT1 | Obesity and hepatic steatosis | Hepatocyte knockout and overexpression models |
| PLIN1 | Lipodystrophy and lipotoxicity | Adipocyte point-mutation and knockout models |
| FASN | Endocrine-resistant breast cancer | Cancer cell line knockout with FASN inhibitor treatment |
| PINK1 | Clear cell renal cell carcinoma therapy resistance | Knockout and mitophagy reporter models |
| SLC27A3 | Lipid remodeling in cancer | Overexpression and tagged knock-in models |
Obesity and lipotoxicity
In obesity, excessive positive regulation of triglyceride storage in adipose tissue initially buffers fatty acids, but when storage capacity is exceeded, lipid spills over into non-adipose tissues and causes lipotoxicity. This mismatch between storage and oxidation is a central mechanism linking obesity to insulin resistance and organ dysfunction. Studying GO:0010890 helps define the threshold at which protective storage becomes pathogenic.
Chronic liver disease and steatosis
Convergent somatic mutations in metabolism genes have been identified in chronic liver disease, implicating altered lipid handling in disease progression. Hepatocellular triglyceride accumulation is a hallmark of steatotic liver disease, and genes that positively regulate triglyceride storage may modify disease severity. Experimental models of hepatocyte lipid storage are therefore valuable for dissecting causal variants.
Cancer lipid metabolic reprogramming
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. This suggests that positive regulation of triglyceride storage can support cancer cell survival and influence therapeutic response. In clear cell renal cell carcinoma, STAT2/SLC27A3/PINK1-mediated mitophagy remodels lipid metabolism and contributes to pazopanib resistance. Together, these findings position GO:0010890 as a potential node for metabolic anticancer strategies [3,6].
Endocrine and inflammatory crosstalk
The endocrine system interacts with inflammation as a function of energy and volume regulation, indirectly shaping triglyceride storage. Neuroendocrine factors such as FGF21 further modulate lipid handling in primates, indicating systemic control of storage processes. These connections suggest that GO:0010890 is relevant beyond classical metabolic tissues [7,8].
From positive regulation of triglyceride storage-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce triglyceride storage? | CRISPR knockout in adipocyte or hepatocyte cell line |
| Does a specific variant alter storage capacity? | Point-mutation knock-in at the endogenous locus |
| Can a tag track lipid droplet protein dynamics? | Tagged knock-in of PLIN2 or PLIN1 |
| Does overexpression increase triglyceride sequestration? | Stable overexpression of DGAT1 or CIDEC |
| Which genes causally regulate lipid storage? | Genome-wide CRISPR library screening with lipid droplet imaging |
| How does mitophagy remodeling affect storage? | PINK1 knockout and rescue in cancer cells |
How to Study the positive regulation of triglyceride storage Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid droplet fluorescence imaging | Number, size, and intensity of lipid droplets | High-content CRISPR screens for storage regulators |
| Triglyceride colorimetric assay | Total cellular triglyceride content | Validation of knockout or overexpression effects |
| RNA-seq | Expression of lipogenic and lipid droplet genes | Mechanistic profiling of storage programs |
| Lipidomics | Triglyceride species and fatty acid composition | Characterizing storage lipid remodeling |
| Proteomics of lipid droplets | Protein composition of droplet fractions | Identifying stabilizing coat proteins |
| Lipolysis assay | Rate of glycerol or fatty acid release | Distinguishing storage from breakdown |
| Mitophagy flux assay | Mitochondrial turnover and remodeling | Linking PINK1 to lipid storage |
| miRNA profiling | Expression of storage-suppressing microRNAs | Identifying negative regulators such as miR-192* |
Lipid droplet imaging and quantification
Fluorescent neutral lipid dyes and lipid droplet protein reporters allow direct visualization and quantification of triglyceride storage at single-cell resolution [1,5]. High-content imaging can be combined with CRISPR perturbations to identify genes that positively regulate storage. Time-lapse imaging captures droplet growth and turnover dynamics.
Transcriptomic and lipogenic gene profiling
RNA-seq and targeted expression panels measure changes in lipogenic and lipid droplet genes such as DGAT1, DGAT2, PLIN1, and PLIN2. These approaches help distinguish increased synthesis from reduced lipolysis as the mechanism of positive regulation. MicroRNA profiling can reveal post-transcriptional regulators such as miR-192*.
Proteomics and lipidomics
Proteomic analysis of lipid droplet fractions identifies coat proteins and associated factors that stabilize stored triglyceride. Lipidomics quantifies triglyceride species and reveals shifts in fatty acid composition. Together, these methods provide a molecular signature of enhanced triglyceride sequestration [1,6].
Functional metabolic assays
Triglyceride content assays, lipolysis measurements, and fatty acid oxidation flux experiments determine whether a perturbation increases net storage [1,3]. Seahorse and isotope tracing can distinguish storage from oxidation. These functional readouts are essential to confirm causal positive regulation of triglyceride storage [1,3].
How CRISPR Can Be Used to Study GO:0010890 positive regulation of triglyceride storage
Knockout
CRISPR knockout of candidate genes such as DGAT1, PLIN1, or PINK1 is used to test whether loss of function reduces triglyceride storage [1,3]. Knockout adipocyte and hepatocyte models provide clean genetic backgrounds for quantifying lipid droplet phenotypes. In cancer cells, knockout can reveal dependencies linked to lipid metabolic reprogramming.
Point Mutation
Point-mutation knock-in allows researchers to model specific variants in metabolism genes associated with chronic liver disease or lipodystrophy. By introducing a single amino acid change at the endogenous locus, the effect on triglyceride storage can be attributed to that variant rather than to protein loss. This approach is valuable for functional interpretation of somatic mutations.
Knock-in
Tagged knock-in of lipid droplet proteins such as PLIN2 enables live-cell tracking of droplet dynamics without overexpression artifacts. Knock-in of reporter cassettes can also be used to monitor transcriptional activation of storage programs. These models support precise mechanistic studies of positive regulation of triglyceride storage.
Overexpression
Overexpression of genes such as DGAT1, CIDEC, or SLC27A3 tests sufficiency for increasing triglyceride sequestration [1,3]. Stable overexpression models are useful for gain-of-function screens and for testing whether a gene is sufficient to drive storage. Combining overexpression with lipid droplet imaging provides a direct readout of positive regulation [1,3].
How EDITGENE Supports positive regulation of triglyceride storage Research
Researchers studying positive regulation of triglyceride storage-related genes often need to determine whether a candidate gene is causally involved in lipid sequestration or merely correlated with it. CRISPR-based perturbation, combined with quantitative lipid droplet readouts, provides the cleanest way to establish causality. EDITGENE offers end-to-end cell model generation and screening services tailored to triglyceride storage biology.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of triglyceride storage research.
Frequently Asked Questions About positive regulation of triglyceride storage
What is GO:0010890 positive regulation of triglyceride storage?
GO:0010890 is a Gene Ontology biological process term defined as any process that increases the rate, frequency or extent of sequestering triglyceride, the storage form of metabolic energy.
What genes are involved in positive regulation of triglyceride storage?
Key genes include DGAT1, DGAT2, PLIN1, PLIN2, PPARG, SREBF1, FASN, SCD, PINK1, SLC27A3, and STAT2, among others [1,3,6].
How is triglyceride storage regulated in adipocytes?
Adipocyte triglyceride storage is regulated by a balance of lipogenic gene expression, lipid droplet coat proteins, and suppression of lipolysis, with microRNAs such as miR-192* able to impair storage [1,5].
Why is triglyceride storage important in obesity?
In obesity, triglyceride storage buffers excess fatty acids, but when capacity is exceeded, lipotoxicity contributes to insulin resistance and organ dysfunction.
Can CRISPR be used to study triglyceride storage?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models are widely used to test causal effects on triglyceride sequestration [1,2,3].
What methods measure triglyceride storage?
Common methods include lipid droplet fluorescence imaging, triglyceride colorimetric assays, lipidomics, RNA-seq, proteomics, and lipolysis assays [1,6].
Is triglyceride storage linked to cancer?
Yes, lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells.
How does PINK1 affect lipid metabolism?
PINK1 is part of the STAT2/SLC27A3/PINK1 mitophagy axis that remodels lipid metabolism and contributes to pazopanib resistance in clear cell renal cell carcinoma.
What is the role of FGF21 in lipid storage?
FGF21 is a neuroendocrine regulator that modulates lipid handling and energy balance, indirectly influencing triglyceride storage.
What experimental models are best for studying GO:0010890?
Adipocyte, hepatocyte, and cancer cell lines with CRISPR perturbations, combined with lipid droplet imaging and triglyceride quantification, are widely used [1,3,6].
Conclusion
GO:0010890 positive regulation of triglyceride storage is a central biological process that determines how cells buffer excess fatty acids into lipid droplets. Its dysregulation underlies obesity, lipotoxicity, chronic liver disease, and cancer metabolic reprogramming [1,2,6]. A growing set of genes, from DGAT1 and PLIN1 to PINK1 and SLC27A3, provides mechanistic entry points for experimental dissection [1,3]. By combining CRISPR knockout, point-mutation knock-in, tagged knock-in, overexpression, and library screening with quantitative lipid assays, researchers can establish causal links between specific genes and triglyceride sequestration [1,2,3,6]. EDITGENE supports these efforts with publication-ready cell models and bioinformatics services tailored to triglyceride storage biology.
References
- 1. Engin A. 2024. Lipid Storage, Lipolysis, and Lipotoxicity in Obesity.. Adv Exp Med Biol 1460:97-129 PMID: 39287850
- 2. Ng SWK et al.. 2021. Convergent somatic mutations in metabolism genes in chronic liver disease.. Nature 598(7881):473-478 PMID: 34646017
- 3. Lu D et al.. 2024. STAT2/SLC27A3/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma.. Research (Wash D C) 7:0539 PMID: 39600540
- 4. Kovanen PT et al.. 1975. Regulation of cholesterol synthesis and storage in fat cells.. J Lipid Res 16(3):211-23 PMID: 1127358
- 5. Mysore R et al.. 2016. MicroRNA-192* impairs adipocyte triglyceride storage.. Biochim Biophys Acta 1861(4):342-51 PMID: 26747651
- 6. Ward AV et al.. 2025. Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells.. Breast Cancer Res 27(1):32 PMID: 40055794
- 7. Straub RH. 2014. Interaction of the endocrine system with inflammation: a function of energy and volume regulation.. Arthritis Res Ther 16(1):203 PMID: 24524669
- 8. Gillum MP. 2018. Parsing the Potential Neuroendocrine Actions of FGF21 in Primates.. Endocrinology 159(5):1966-1970 PMID: 29608670
